PURPOSE: To determine the efficacy of percutaneous sclerotherapy with
an alcoholic solution of zein in lymphangiomas in pediatric patients.
MATERIALS AND METHODS: Fourteen patients with macrocystic and mixed ly
mphangiomas were treated with use of Ethibloc as a sclerosing agent. T
he procedure was performed with ultrasonographic and/or fluoroscopic g
uidance. Follow-up clinical and sequential computed tomographic examin
ations were performed to evaluate regression of the lesion. RESULTS: R
egression was excellent in nine (64%) of the 14 lesions: Regression wa
s complete in four lymphangiomas and was to less than 5% of the initia
l volume in five. Satisfactory results were obtained in the remaining
five (36%) of 14 lesions. The most frequent complication was leakage o
f Ethibloc without important sequelae in 10 of the 14 lymphangiomas. C
ONCLUSION: Percutaneous sclerotherapy with Ethibloc was a safe and eff
ective procedure in the treatment of macrocystic and mixed lymphangiom
as.